What is it?
Psilocybe mexicana stands as the most historically significant psilocybin-containing mushroom species -
the organism from which Albert Hofmann first isolated psilocybin in 1958, launching modern psychedelic
science.
**Taxonomy and Classification**
- Family: Hymenogastraceae (previously Strophariaceae)
- Order: Agaricales
- First formally described by Roger Heim in 1957 in *Revue de Mycologie*
**Physical Description**
- Cap: 1-2 cm diameter, conic to campanulate with slight papilla, ocherous to brown, viscid when moist
- Stem: 4-10 cm tall, 1-2 mm wide, hollow, straw to brownish, no ring
- Gills: Adnate to adnexed, gray to purple-brown with whitish edges
- Spore print: Dark purple-brown
- Key feature: Strong blue bruising when handled (confirms psilocybin content)
**Chemical Profile**
Contains 0.33-0.39% psilocybin and 0.19-0.20% psilocin by dry weight, making it lower potency than
P. cubensis (~0.6-1.3%) but ideal for gentle, predictable microdosing.
**Sclerotia (Truffles)**
Critically, P. mexicana forms sclerotia - underground truffle-like structures with lower alkaloid
concentrations (0.059-0.168% psilocybin fresh weight). These are legally sold in Netherlands smart shops.
**Typical Microdose:** 0.15-0.35g dried mushrooms or 0.5-1.5g fresh truffles
🚨 Important Warnings
Please read all warnings carefully before use.
NEVER combine psilocybin with lithium. Documented 47% seizure rate with some fatalities. Wait at least 30 days after lithium discontinuation.
Avoid use with personal history of psychosis, schizophrenia, or bipolar I disorder. Psychosis incidence: 0.6% in clinical trials vs 3.8% with schizophrenia history.
Potency varies up to 10-fold between individual specimens. Always homogenize batches before dosing and use a precision scale (0.01g minimum).
Legal status varies significantly by jurisdiction. Verify local laws before any activity. Note: Truffles are legal in the Netherlands but mushrooms are not.
This information is for harm reduction only, not medical advice. Consult a healthcare professional, especially if you take medications or have health conditions.
⚠️ Interactions & Combinations
Important information about drug interactions and combinations. Always consult a physician before combining.
Lithium
Seizure risk and severe adverse reactions
In a review of 62 lithium + psychedelic reports, 47% involved seizures and 39% required emergency medical care, with some fatalities. This is the most dangerous known interaction.
MAOIs (Monoamine Oxidase Inhibitors)
Potentiation and serotonin syndrome risk
MAOIs inhibit psilocin breakdown, causing prolonged and intensified effects with unpredictable potentiation. Especially dangerous with ayahuasca combinations.
Tramadol
Lowered seizure threshold and serotonergic risk
Tramadol lowers seizure threshold and has serotonergic activity, increasing both seizure and serotonin syndrome risk when combined with psychedelics.
SSRIs (Selective Serotonin Reuptake Inhibitors)
Reduced effects (5-HT2A downregulation)
47-55% of users report reduced psilocybin effects when taking SSRIs. Serotonin syndrome risk appears low in studies. Do NOT abruptly discontinue SSRIs to use psilocybin.
Antipsychotics
Blocking effects (5-HT2A antagonism)
Antipsychotics block 5-HT2A receptors and can completely stop psychedelic effects. Risperidone at 1 mg abolished 98-99% of psilocybin effects in one study.
Cannabis
Unpredictable intensification
Cannabis can unexpectedly intensify effects and increase anxiety or paranoia. Many adverse event reports involve polysubstance use including cannabis. May increase HPPD risk.
Lamotrigine
Minimal interaction - safer alternative to lithium
Appears safer than lithium for mood stabilization. 65% reported no effect on psychedelic experience with zero seizure reports. May be a reasonable option for bipolar patients.
💊 Dosage Guidelines
Typical dosage ranges from sub-perceptual microdoses to full psychoactive doses
Microdose
0.15 g
Sub-perceptual
Threshold
0.4 g
First noticeable effects
Moderate
2.0 g
Full effects
Strong
4.0 g
Intense experience
📋 Microdosing Protocols
Recommended protocols and regimens for microdosing this substance.
Fadiman Protocol
Dosage:
P. mexicana: Start 0.1-0.15g dried; typical 0.15-0.35g dried. Truffles: 0.5-1.5g fresh.
Schedule:
1 day on, 2 days off
The most widely recommended starting protocol, developed by Dr. James Fadiman. The two-day break prevents tolerance buildup and allows observation of both immediate and lasting effects.
Detailed Schedule:
- Day 1: Take microdose in the morning
- Day 2: Transition day - observe afterglow
- Day 3: Baseline day
- Day 4: Repeat cycle
Stamets Protocol (Stamets Stack)
Dosage:
P. mexicana: 0.15-0.3g dried; lion's mane 500-2000mg; niacin 25-50mg (flush-inducing).
Schedule:
4 days on, 3 days off
Combines psilocybin with lion's mane and niacin for hypothesized neurogenesis benefits. Note: The 2022 Rootman study found this combination did NOT enhance mood/mental health outcomes beyond psilocybin alone.
Detailed Schedule:
- Days 1-4: Take all three components each morning
- Days 5-7: Rest (optional lion's mane only)
- Repeat for 4 weeks
- Take a 2-4 week break before the next cycle
✨ Reported Effects
Enhanced Creativity
Subtle improvements in divergent thinking and novel idea generation. Effects are gentler than higher-potency species.
Mood Enhancement
Reported improvements in emotional well-being and reduced rumination. Studies show small to medium improvements in observational research.
Gentle Introspection
Subtle increase in self-awareness without overwhelming intensity. Well-suited for those new to psychedelics.
Neuroplasticity
Psilocybin promotes structural changes in neurons and increased brain connectivity, potentially supporting learning and adaptation.
⚠️ Safety Information
Psilocybin has an excellent safety profile with low physiological toxicity (LD50 over 1,000x therapeutic
dose) and no documented physical dependence. However, critical safety considerations apply:
ABSOLUTE CONTRAINDICATION: Never combine with lithium - documented 47% seizure rate in case reports,
with some fatalities. Wait at least 30 days after lithium discontinuation.
Avoid use with personal history of psychosis, schizophrenia, or bipolar I disorder. Use caution with
SSRIs (may reduce effects), MAOIs (potentiation and serotonin syndrome risk), and tramadol (seizure risk).
Start with the lowest dose (100-150 mg for P. mexicana) and increase gradually. Potency varies up to
10-fold between individual specimens - always homogenize batches before dosing. Use a precision scale
(0.01g minimum). If you experience any perceptual changes, the dose is too high.
🔬 Scientific Research
Current research findings and clinical studies.
Found microdosing produces measurable changes in neurobiology, physiology, and subjective experience relative to placebo - evidence against a pure placebo explanation.
Found no overall cognitive benefit (Cohen's d = -0.06) and significant decrease in cognitive control (d = -0.34). Expectancy effects appear to account for many self-reported benefits.
Small-to-medium improvements in mood and mental health among microdosers. Importantly, the Stamets Stack did NOT enhance outcomes beyond psilocybin alone.
High-dose psilocybin produced large, sustained decreases in depression and anxiety. 80% showed clinically significant improvement at 6-month follow-up. 67% rated experience among top 5 most meaningful of their lives.
Demonstrated that psilocybin decreases activity and connectivity within the Default Mode Network (DMN). This disruption correlates with ego-dissolution experiences and may underlie antidepressant effects.
⚖️ Legal Status
Current legal status in various jurisdictions. Always respect local laws.
| Jurisdiction | Status | Details |
|---|---|---|
|
Czech Republic
(2025) |
Medical use legalized (effective 2026)
|
Parliament approved medical psilocybin in 2025, effective January 1, 2026. First EU country with nationwide medical legalization. Only synthetic psilocybin for treatment-resistant depression and cancer-related depression; administered by certified psychiatrists; max 75 mg/month. 68% of Czechs surveyed support medical psychedelic use. |
|
Netherlands
(2008) |
Mushrooms illegal / Fresh truffles legal
|
Psilocybin mushrooms banned in 2008, but fresh psilocybin truffles (sclerotia) remain legal and sold in smart shops. Only fresh truffles are legal; dried or processed truffles are illegal. P. mexicana truffles are commonly available. |
|
Australia
(2023) |
Schedule 8 - Medical use for treatment-resistant depression
|
Reclassified from Schedule 9 to Schedule 8 on July 1, 2023 for treatment-resistant depression only. Prescribing restricted to psychiatrists via the Authorised Prescriber Scheme in supervised medical settings. |
|
Oregon, USA
(2020) |
Legal - Regulated services
|
Measure 109 (2020) established regulated psilocybin services, operational since 2023. Licensed service centers for adults 21+; no prescription required; includes preparation, administration, and integration sessions. |
|
Colorado, USA
(2022) |
Decriminalized + Regulated services (2025)
|
Proposition 122 (2022) decriminalized personal use for adults 21+ and established licensed "healing centers" - first licenses issued March 2025. |
| Jamaica |
No prohibition - Fully legal
|
Psilocybin mushrooms were never prohibited in Jamaica. Fully legal for possession, sale, and cultivation. Numerous retreat centers operate legally. |
|
United States (Federal)
(1970) |
Schedule I - Illegal
|
Remains Schedule I under the Controlled Substances Act. Federal prosecution possible even in states with legal programs. FDA granted "breakthrough therapy" designation in 2018 and 2019 for clinical trials. |
|
Portugal
(2001) |
Decriminalized for personal use
|
All drugs decriminalized for personal use. Fresh mushrooms up to 5g; dried up to 0.5g considered personal use. Not legal for sale or cultivation. |
👤 Key Figures
Notable figures associated with the research and history of this substance.
R. Gordon Wasson
Ethnomycologist, J.P. Morgan vice president
First Westerner to document a traditional psilocybin ceremony (1955 in Oaxaca with María Sabina). His 1957 Life magazine article introduced "magic mushrooms" to Western culture and sparked the modern psychedelic movement.
María Sabina
Mazatec curandera (healer)
Practiced velada mushroom ceremonies for over 30 years before Western contact. Her 1955 ceremony with Wasson introduced sacred mushroom traditions to the world. Called the mushrooms "los Niños Santos" (the Holy Children).
Roger Heim
French mycologist, Muséum National d'Histoire Naturelle director
Accompanied Wasson on 1956 expedition. Provided first scientific descriptions of P. mexicana in 1957. Successfully cultivated the species in his laboratory, enabling Hofmann's chemical analysis.
Albert Hofmann
Swiss chemist (Sandoz Laboratories)
Isolated psilocybin and psilocin from P. mexicana specimens in 1958, enabling scientific study. Also discovered LSD (1943). Consumed 32 mushrooms to confirm retained psychoactivity. Visited María Sabina in 1962 with synthetic psilocybin pills.
Gastón Guzmán
Mexican mycologist, taxonomist
World's leading expert on Psilocybe taxonomy. Authored major taxonomic works on the genus, describing over 200 new species of mushrooms throughout his career.
James Fadiman
Psychologist, microdosing researcher
Known as the "father of modern microdosing." Developed the Fadiman Protocol (1 day on, 2 days off), authored "The Psychedelic Explorer's Guide" (2011), and collected thousands of microdosing reports from 30+ countries.
📚 Scientific Research
Johns Hopkins Center for Psychedelic Research
Leading research center conducting psilocybin clinical trials for depression, addiction, and end-of-life distress.
https://hopkinspsychedelic.org/Imperial College Centre for Psychedelic Research
UK-based research center pioneering brain imaging studies and clinical trials with psilocybin.
https://www.imperial.ac.uk/psychedelic-research-centre/Erowid Psilocybin Vault
Comprehensive database of psilocybin mushroom information, experience reports, and harm reduction resources.
https://erowid.org/plants/mushrooms/MAPS (Multidisciplinary Association for Psychedelic Studies)
Non-profit organization funding and conducting psychedelic research and education.
https://maps.org/❓ FAQ
How does P. mexicana compare to P. cubensis?
P. mexicana is approximately 40-50% the potency of P. cubensis, meaning you need 1.5-2x the dose for
equivalent effects. This makes it excellent for beginners seeking gentler, more controllable experiences.
It also forms sclerotia (truffles), which P. cubensis does not.
Can I use sclerotia (truffles) for microdosing?
Yes, P. mexicana truffles are commonly used for microdosing, especially in the Netherlands where they
are legal. Typical truffle microdose: 0.5-1.5g fresh. Note that truffles have lower alkaloid content
than fruiting bodies (0.059-0.168% vs 0.33-0.39% psilocybin).
How should I store P. mexicana?
Store dried mushrooms in airtight containers with silica gel desiccant in a cool (10-21°C), dark place.
Properly stored dried mushrooms last 6-24 months. Fresh truffles should be refrigerated and used within
1-2 weeks. Avoid light exposure, which degrades psilocybin through photooxidation.
Is P. mexicana legal in the Czech Republic?
As of January 2026, synthetic psilocybin is legal for medical use in the Czech Republic for
treatment-resistant depression and cancer-related depression, administered by qualified psychiatrists.
Natural mushrooms remain controlled substances for personal possession.
What protocols work best for P. mexicana?
Both the Fadiman Protocol (1 day on, 2 days off) and Stamets Stack (4 days on, 3 days off) work well.
Adjust doses upward compared to P. cubensis protocols. The Stamets Stack combination with lion's mane
and niacin did not enhance mood/mental health outcomes beyond psilocybin alone in the 2022 Rootman study.
How do I know if my dose is correct?
A proper microdose should be sub-perceptual - you should NOT experience any visual changes, altered
thinking, or obvious psychoactive effects. If you notice these, reduce your dose. Effects should be
subtle: perhaps slightly improved mood, marginally better focus, or enhanced creativity.
Important Legal Notice
⚠️ Personal Responsibility
You use this application entirely at your own risk and responsibility. MicrodosingDiary is only a tool for recording personal experiences.
🚫 Not a Medical Service
This application IS NOT a medical tool, does not provide medical advice, does not diagnose or treat any conditions. Always consult a qualified physician.
⚖️ Legislation and Laws
Many substances used for microdosing are illegal in many countries. Users are fully responsible for complying with local laws. The application does not support or promote illegal activity.
❌ No Guarantees
We provide no guarantees regarding results, safety or efficacy of microdosing. All information is for informational purposes only.
🔞 Age Restriction
Application is intended only for persons over 18 years of age. By using the application you confirm that you are an adult.
🔒 Data Privacy
Your data is private and encrypted. We never share it with third parties without your consent. Application is for personal use only.
By using this application you accept all the above risks and waive any claims against the application operator.